Randall Stevens

Randall Stevens, M.D. joined Centrexion Therapeutics as the chief medical officer in April 2015. Randall is a board-certified internist and rheumatologist with more than 25 years of experience in pharmaceutical medicine. Prior to joining Centrexion, he served as the corporate vice president, head of inflammation and immunology clinical development for Celgene Corporation. Earlier in his career, Randall spent 11 years at F. Hoffmann La Roche where he was a global leader in inflammation and immunology clinical research. In total, Randall has played an integral role in bringing five drugs to market. Additionally, he has been a clinical professor of medicine at Robert Wood Johnson School of Medicine since 1990 and a board member for Outcome Measures Rheumatic Clinical Trails (OMERACT) since 2007. Randall has authored or co-authored more than 40 peer-reviewed publications. He holds a B.A. in chemistry and Spanish, and a M.D. from Case Western Reserve University School of Medicine.